JPRN-UMIN000003992
Completed
Phase 3
RCT of Tri-Modalities with I-125 Brachy Therapy and EBRT and Short or Long Term Hormone Therapy for High-risk Localized Prostate Cancer - RCT of Tri-Modalities with I-125 Brachy Therapy and EBRT and Short or Long Term Hormone Therapy for High-risk Localized Prostate Cancer (TRIP Study)
Kanazawa University Translational Research Informatices Center0 sites340 target enrollmentAugust 5, 2010
ConditionsProstate Cancer
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- Prostate Cancer
- Sponsor
- Kanazawa University Translational Research Informatices Center
- Enrollment
- 340
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Patients who have active double cancer 2\) Patients with poorly controlled hypertension (i.e., diastolic blood pressure\>\=120 mm Hg) 3\) Patients with severe psychiatric disorders 4\) Patients with collagen diseases 5\) Patients with poorly controlled diabetes 6\) Patients with poorly controlled ischemic cardiac disease 7\) Patients who had prior surgery for prostate (transurethral prostatectomy, radical prostatectomy, orchiectomy, other surgery for BPH and/or hyperthermia) 8\) Patients who had brachytherapy and/or EBRT 9\) Patients who are taking steroid drugs (except for ointment) 10\) Patients who are taking other antiandrogen for BPH 11\) Patients who had CAB for more than 3 months prior to the registration 12\) Patients who are judged inappropriate for the clinical trial by doctors
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 3
Clinical Trial for Tri-Modality Therapy with I-125 Brachytherapy, External Beam Radiation Therapy, and Short- or Long-term Hormone Therapy for High-Risk Localized Prostate CancerProstate CancerJPRN-jRCTs031180252AMIKI Mikio349
Completed
Not Applicable
Multicatheter interstitial brachytherapy (MIBT) based accelerated partial breast irradiation (APBI) - dosimetric comparison with external beam radiotherapy and report on early outcomes in terms of toxicity and local controlHealth Condition 1: null- Post Surgery For Breast CancerCTRI/2018/01/011300ot Applicable21
Active, not recruiting
Phase 3
SHIP0804JPRN-jRCTs031180256Egawa Shin420
Recruiting
Not Applicable
Clinical Outcome of Multicatheter Brachytherapy APBI in breast-conserving Therapy (COMBAT)for breast cancer patients-A(adjuvant),-C(complications and cosmesis)breast cancerJPRN-UMIN000029907Tokyo-West Tokushukai Hospital Breast oncology center850
Recruiting
Not Applicable
Clinical Outcome of Multicatheter Brachytherapy APBI in breast-conserving Therapy (COMBAT) for breast cancer patients after neoadjuvant chemotherapyBreast CancerJPRN-UMIN000026976Tokyo-West Tokushukai Hospital30